SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028322
Filing Date
2016-11-08
Accepted
2016-11-08 16:06:22
Documents
62
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mstx-10q_20160930.htm 10-Q 1255975
2 EX-31.1 mstx-ex311_6.htm EX-31.1 16096
3 EX-31.2 mstx-ex312_7.htm EX-31.2 16128
4 EX-32.1 mstx-ex321_8.htm EX-32.1 10754
  Complete submission text file 0001564590-16-028322.txt   4171365

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mstx-20160930.xml EX-101.INS 732692
6 XBRL TAXONOMY EXTENSION SCHEMA mstx-20160930.xsd EX-101.SCH 40572
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mstx-20160930_cal.xml EX-101.CAL 30223
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mstx-20160930_def.xml EX-101.DEF 97949
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mstx-20160930_lab.xml EX-101.LAB 269271
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mstx-20160930_pre.xml EX-101.PRE 205116
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 161981339
SIC: 2834 Pharmaceutical Preparations